AGP Picks
View all

Jordan Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jordan Healthcare Press.

Press releases published on November 16, 2026

INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA
Allarta Life Science moves Canadian-developed type 1 diabetes cell therapy closer to the clinic with Breakthrough T1D award
VIVUS Announces Preferred Formulary Status for PANCREAZE® Across Major National Medicare Formulary
Four students, one shared goal: a healthier Saskatchewan
Lantheus Presents Data from Two Pivotal Phase 3 Studies of TAUKLARIFY (Florquinitau F 18 Injection) PET Imaging in Early Alzheimer’s Disease
AliveCor and PulseAI Partner to Bring Advanced Cardiac AI Determinations and Clinical Care Platform to Major Consumer Wearables
Precision Neuroscience and Team Gleason Partner to Give the ALS Community a Voice in Brain–Computer Interface Development
Tris Pharma Named a BioSpace 2027 Best Places to Work Winner
Vaso Corporation Announces Financial Results for Third Quarter of 2026
HealthEdge Introduces AI Strategy to Protect Health Plans From Unpredictable AI Costs
Diakonos Oncology Presents DOC1021 Data Showing Encouraging Survival Signal in Newly Diagnosed Glioblastoma at SNO 2026
Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026
New Study: Faster is Better for Alzheimer’s Prevention
Pinnacle Treatment Centers Opens Columbus Treatment Services, Expanding Access to Addiction Treatment on Columbus' West Side
Ziphius, a leading saRNA biotech, today announces the appointment of Mr. Antoon Loomans to its Board of Directors
AI-Driven Mobile Genomics Poised for Disruption as Edge Computing and Portable Sequencing Converge
Corxel US Presents Full Phase 2 Results for CX11 in Adults with Overweight and Obesity at ObesityWeek® 2026
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
Nuo Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Jordan Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.